2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Size: px
Start display at page:

Download "2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation."

Transcription

1 DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart Institute 2 Issues Specific to Transplantation Kidney Transplantation Operative risk Liver>Lung>Kidney Cardiac risk factors common in these patients Special Considerations for Transplantation Donated organ is a scarce resource Possible changes in risk while waiting Cardiac risks over the years post Medium Risk Surgery both a vascular and abdominal surgery Long waiting time Most potential candidates have multiple risk factors for CAD/stroke HTN, DM, etc.. Primary causes of post tx mortality are cardiovascular 3 4 Kidney Transplant Case Question 1 55 M with DM type 1 since childhood and longstanding HTN. He has CKD stage 4 due to DM, but is not yet on hemodialysis. He exercises daily with brisk walking. He denies CP, SOB, orthopnea, PND, or edema. He denies syncope, presyncope or palpitations. He is disabled from his job as a salesman due to his decreased vision. What evaluation does this patient need? A. EKG only B. Stress test. C. Coronary angiography regardless of stress test results. D. He is not a candidate for kidney due to cardiac risk factors. 1

2 ACC/AHA guidelines ACC/AHA guidelines discourage pre op screening of asymptomatic patients Testing doesn t improve operative outcomes 770 patients with 1-2 cardiac risk factors undergoing intermediate risk surgery were randomized to stress testing or no testing No difference in death or MI at 30 days or beyond Testing delayed surgery by 3 weeks Fleisher L A et al. Circulation 2007;116: Poldermans D et al. JACC 2006; 48: Renal candidates are treated differently Pre Kidney Transplant Case 55 M with DM type 1 since childhood and longstanding HTN. He has CKD stage 4 due to DM and is not yet on hemodialysis He exercises daily with brisk walking. He denies CP, SOB, orthopnea, PND, or edema. He denies syncope, presyncope or palpitations. He is disabled from his job as a salesman due to his decreased vision. Friedman S E et al. CJASN 2011;6: Question 1 Question 2 What evaluation does this patient need? A. EKG only B. Stress test. C. Coronary angiography regardless of stress test results. D. He is not a candidate for kidney due to prior CAD. Nuclear adenosine stress test shows a large reversible defect in the anterior wall consistent with a proximal LAD lesion. Based on the abnormal stress test, you decide: A. Medical management. B. Coronary angiogram. C. Repeat stress testing in 1 year. D. He is no longer a kidney candidate due to an abnormal stress test. 2

3 Kidney Transplant Coronary Artery Evaluation Question 2 No symptoms Low risk finding Abnormal stress test Anginal symptoms High risk finding Nuclear adenosine stress test shows a large reversible defect in the anteroseptum and anterolateral wall consistent with a proximal LAD lesion. Based on the abnormal stress test, you decide: Medical management Stents List for Angiogram CABG No targets Not a candidate for A. Medical management. B. Coronary angiogram. C. Repeat stress testing in 1 year. D. He is no longer a kidney candidate due to an abnormal stress test. Question 3 Preoperative cardiovascular risk assessment Coronary angiogram shows a 90% proximal LAD lesion with no other disease. What should the cardiologist do? A. Continue medical management and list the patient for kidney. B. Perform FFR of the LAD lesion. C. Stent the LAD lesion. D. Decline the patient for kidney ation due to the severe LAD stenosis. Revascularization doesn t improve outcomes 510 patients scheduled for vascular surgery with significant CAD and stable symptoms were randomized to revascularization or no revascularization No difference in death or MI at 30 days or beyond McFalls E et al. NEJM 2004; 351: For Kidney Tx Candidates, is revascularization better? Kidney Transplant Coronary Artery Evaluation Observational study of 1460 patients referred for kidney evaluation Low risk finding Abnormal stress test Medically managed CAD is a risk factor for poor outcomes No symptoms Anginal symptoms High risk finding But... does revascularization really help? Revascularized patients were more likely to receive aspirin, beta blocker, and statin therapy Angiogram Bottom line: Revascularization should be considered... but so should optimal medical management Medical management Stents List for CABG No targets Not a candidate for Kahn M et al. Am J Transplant 2011; 11: Kittleson MM et al. Am J Transplant 2011; 11:

4 Question 3 Question 4 Coronary angiogram shows a 90% proximal LAD lesion with no other disease. What should the cardiologist do? A. Continue medical management and list the patient for kidney. B. Perform FFR of the LAD lesion. C. Stent the LAD lesion. D. Decline the patient for kidney ation due to the severe LAD stenosis. The patient has stent of LAD lesion and is listed for a deceased donor kidney. Given the long projected wait time, the patient is listed one week after stent placement while on aspirin and clopidogrel. What surveillance is needed? A. Annual nuclear adenosine stress tests. B. Annual coronary angiograms. C. Annual cardiology consultations. Question 4 The patient is listed for a deceased donor kidney. Given the long projected wait time, the patient is listed one week after stent placement while on aspirin and clopidogrel. What surveillance is needed? A. Annual nuclear adenosine stress tests. B. Annual coronary angiograms. C. Annual cardiology consultations.* *He should have regular follow-up appointments with his cardiologist Low EF Assess for reversible causes: stress test/angio Initiate evidence based therapy with ACEI and BB Optimize fluid balance and BP NYHA I II List for kidney Impaired Ventricular Function NYHA III IV Consider heart kidney if eligible Severe AS HF symptoms Low EF Dilated ventricle Valve surgery Severe AR/MR Valvular Heart Disease No HF Normal EF Normal LV size Moderate AS/AR/MR Pre op Cardiac Liver Transplant Evaluation High operative hemodynamic stress: hypotension acidosis aorta cross clamping afterload transient high preload electrolyte and calcium imbalances List for Annual echocardiograms for all patients while on waiting list Bonow RO et al. Circulation 2008; 118: e523-e

5 Liver Transplant Evaluation Potential co existing cardiovascular problems: CAD (25%) infiltrative cardiomyopathies (amyloid, hemochromatosis, sarcoid) Alcoholic cardiomyopathy Cirrhotic Cardiomyopathy long QT interval pulmonary hypertension Liver candidate History/physical exam Electrocardiogram Echocardiogram Pre op Cardiac Evaluation for Liver Transplant Normal evaluation Abnormal electrocardiogram Abnormal history/physical Abnormal echocardiogram Age > 40 Risk factors for CAD No No further testing Yes Q waves, ST-T changes, LVH, BBB Normal Stress test Age > 60y Diabetes > 5 y Symptoms of ischemia History of CAD Abnormal Coronary angiogram EF < 40% Wall motion abnormalities RVSP > 40 mm Hg Right heart catheterization 26 Cardiovascular Contraindications to Liver Transplant Coronary Artery Disease: not amenable to revascularization excessive bleeding risk for PCI/surgery (Childs Class B,C) LVEF less than 40% Severe valvular disease not a candidate for repair/replacement Severe, irreversible pulm HTN Preoperative Cardiac Evaluation for Lung Transplant High incidence of CAD in patients with COPD also increased risk in pulmonary fibrosis Pulmonary HTN can cause RV failure, tricuspid regurgitation both reversible if not severe, longstanding Preoperative Cardiac Evaluation for Lung Transplant Cardiac Evaluation: ecg, echo stress testing if any risk factors for CAD consider coronary angio, RHC for age over 50 or multiple risk factors Possible concurrent surgeries: CABG Valve repairs Heart lung Summary We must consider: both the immediate operative risk and long term cardiac risks The scarce resource of a donor organ risk factors, not just symptoms to determine testing Contraindications: CAD, valvular disease not amenable to treatment Persistent symptoms of CHF?low LVEF Cardiology Consultation and follow up: for abnormal stress tests and high risk patients cardiologist on the team 30 5

6 Pre-Kidney Transplant Cardiac Evaluation All patients: History, Physical, EKG Thank you! Symptoms Abnormal EKG Risk Factors Nuclear adenosine stress test Symptoms Murmur Echocardiogram CAD Heart Failure Valvular disease Arrhythmias High risk ischemia/infarction EF < 45% Mod sev valvular disease Mod sev pulmonary htn Cardiology Consultation 6

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Postoperative Myocardial Infarction: Diagnosis and Management

Postoperative Myocardial Infarction: Diagnosis and Management Postoperative Myocardial Infarction: Diagnosis and Management Todd M. Brown, MD, MSPH Chief Fellow Division of Cardiovascular Diseases December 9, 2008 CHEST PAIN NON-ANGINAL UNSURE ANGINAL STABLE ANGINA

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

In a patient with symptoms consistent with an intermediate pretest probability, is imaging warranted?

In a patient with symptoms consistent with an intermediate pretest probability, is imaging warranted? In a patient with symptoms consistent with an intermediate pretest probability, is imaging warranted? What are the indications for imaging vs standard stress test? 3 Steps for Evaluation Step 1: What is

More information

Heart Failure with Preserved Systolic Function-The Last Frontier of HF J. Thomas Heywood MD

Heart Failure with Preserved Systolic Function-The Last Frontier of HF J. Thomas Heywood MD Heart Failure with Preserved Systolic Function-The Last Frontier of HF J. Thomas Heywood MD Director, Heart Failure Recovery And Research Program Scripps Clinic La Jolla, Ca 2 JACC 2006 Difference between

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Wail Hashimi M.D., FACC Cardiology Associates

Wail Hashimi M.D., FACC Cardiology Associates Wail Hashimi M.D., FACC Cardiology Associates 38 year old female with mild obesity She is planning an exercise program to loose weight. She has no other known risk factors for CAD. You recommend: A. Exercise

More information

Non-cardiac Surgery:Risk Assessment and Management. Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic

Non-cardiac Surgery:Risk Assessment and Management. Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic Non-cardiac Surgery:Risk Assessment and Management Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic Statement of the Problem The number of persons older than 65 years in

More information

Risk Stratification in Chronic Stable Angina. By M.Wafaie Aboleineen,MD,FACC.

Risk Stratification in Chronic Stable Angina. By M.Wafaie Aboleineen,MD,FACC. Risk Stratification in Chronic Stable Angina By M.Wafaie Aboleineen,MD,FACC. Risk Stratification Risk dictates management Predicted annual mortality < 1 % can be managed medically Pts with mortality 1-3

More information

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469)

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Provider Checklist-Outpatient Imaging Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Medical Review Note: Per InterQual, if any of the following are present,

More information

Evaluation of Suspected CAD in 2011

Evaluation of Suspected CAD in 2011 RWC Physicians Conference Evaluation of Suspected CAD in 2011 Nader M. (Nader) Banki, MD Xiushui (Mike) Ren, MD March 4, 2011 Disclosure of Relevant Financial Relationships Under the ACCME Standards for

More information

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip

More information

Exercise Stress Testing. George Le-Bert, DO, FACC Baptist Heart Specialists

Exercise Stress Testing. George Le-Bert, DO, FACC Baptist Heart Specialists Exercise Stress Testing George Le-Bert, DO, FACC Baptist Heart Specialists ACC/AHA-Guidelines The Stress Test has two roles in clinical care: 1. Diagnostic evaluation. 2. Assessment of long-term risk of

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA. Kevin M Hayes D.O.

Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA. Kevin M Hayes D.O. Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA Kevin M Hayes D.O. Objectives Description of cardiac stress test available Indications for use and prognostic information What

More information

OUTLINE. Case presentation Clinical trial data: Evidence Implications for clinical practice

OUTLINE. Case presentation Clinical trial data: Evidence Implications for clinical practice Disclosure: Research Support/Grants: Astra Zeneca, LP, Bristol-Myers Squibb Co, Eli Lilly & Co, and Merck/Schering- Plough Pharmaceuticals Consulting (Clinical Event Committees): F. Hoffman-La Roche and

More information

ADVANCES IN THE MANAGEMENT OF CONGESTIVE HEART FAILURE. Manpreet Singh MD

ADVANCES IN THE MANAGEMENT OF CONGESTIVE HEART FAILURE. Manpreet Singh MD ADVANCES IN THE MANAGEMENT OF CONGESTIVE HEART FAILURE Manpreet Singh MD DISCLOSURE I have no financial disclosures Heart Failure Approximately 5 million Americans have CHF (male to female ratio 1:1) 550,000

More information

Nuclear Stress Testing and Multi- Modality Imaging

Nuclear Stress Testing and Multi- Modality Imaging Nuclear Stress Testing and Multi- Modality Imaging Dr. Steven Mottl Dallas, Tx No Financial Discloures Learning Objectives Order the Right Test for the Right Patient How to risk stratify patients Review

More information

Valvular Heart Disease

Valvular Heart Disease Case #1 Valvular Heart Disease Internal Medicine Board Review Niels Engberding, MD, FACC, FESC Assistant Professor of Medicine Division of Cardiology Emory University of School of Medicine 78 y/o female

More information

Risk Stratification Post MI for Patients at Risk for Sudden Death. Dr. Umang Patel St. Mary s hospital, Evansville, IN

Risk Stratification Post MI for Patients at Risk for Sudden Death. Dr. Umang Patel St. Mary s hospital, Evansville, IN Risk Stratification Post MI for Patients at Risk for Sudden Death Dr. Umang Patel St. Mary s hospital, Evansville, IN Epidemiology The overall incidence of SCD in the United States is 1 to 2 per 1000

More information

A 39 year old woman with new onset dyspnea

A 39 year old woman with new onset dyspnea Dyspnea A 39 year old woman with new onset dyspnea Initial presentation Ms. Hernandez has been well until about 6 months ago when she started to get more short of breath. One day she felt particularly

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

Valvular Heart Disease Case 1: Aortic Stenosis. Case 1: History. Case 1: Objectives. Presenter Disclosure Information

Valvular Heart Disease Case 1: Aortic Stenosis. Case 1: History. Case 1: Objectives. Presenter Disclosure Information Presenter Disclosure Information 4:30 5:15 pm Valvular Heart Disease for the Clinician SPEAKER Joseph Tenenbaum, MD, FACC, FACP The following relationships exist related to this presentation: Joseph Tenenbaum,

More information

Diastolic Heart Failure Easy to diagnose, hard to manage

Diastolic Heart Failure Easy to diagnose, hard to manage Diastolic Heart Failure Easy to diagnose, hard to manage Rami Kahwash, MD Assistant Professor in Internal medicine Section of Heart Failure / Transplant The Ohio State University Orlando, Florida October

More information

Efficient Evaluation of Chest Pain

Efficient Evaluation of Chest Pain Efficient Evaluation of Chest Pain Vikranth Gongidi, DO FACC FACOI Indian River Medical Center Vero Beach, FL No Disclosures Outline Background Chest pain pathway Indications for stress test Stress test

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization

Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization RESCUE Investigators Meeting Kreton Mavromatis MD FACC Atlanta VA Medical Center Emory University School of Medicine Overview

More information

Section H: HEMODYNAMICS AND CARDIAC CATHETERIZATION

Section H: HEMODYNAMICS AND CARDIAC CATHETERIZATION Section H: HEMODYNAMICS AND CARDIAC CATHETERIZATION Section Intent: The intent of this section is to record the cardiac catheterization results in regard to: 1) Coronary Artery Disease 2) Cardiac Hemodymanics,

More information

Valvular Heart Disease management

Valvular Heart Disease management Valvular Heart Disease management Dr Karl Poon MBBS FRACP Interventional cardiologist Structural intervention and TAVI specialist Queensland Cardiovascular Group Outline VHD General principles on diagnosis

More information

2014 University of Maryland Emergency Medicine Residency. ECG Competition. April 30, 2014

2014 University of Maryland Emergency Medicine Residency. ECG Competition. April 30, 2014 2014 University of Maryland Emergency Medicine Residency ECG Competition April 30, 2014 1. Which of the following statements is true regarding Q-waves? a. They are significant for myocardial infarction

More information

Outpatient Heart Failure Management

Outpatient Heart Failure Management Outpatient Heart Failure Management UCVA 4 th Annual Cardiovascular Conference 09/29/2012 Eugene Storozynsky, M.D., Ph.D., F.A.C.C Assistant Professor of Medicine Program in Heart Failure and Transplantation

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2015

More information

Several people undergo regular health check up as awareness

Several people undergo regular health check up as awareness Review Article Evaluation of TMT Abnormalities in Asymptomatic Persons Using Myocardial Perfusion Study MJ Jacob * Abstract Exercise ECG (TMT) is one of the very common investigations being used in the

More information

Aortic Stenosis Challenges

Aortic Stenosis Challenges Aortic Stenosis Challenges Krishna Rao, MD FACC Associate Professor of Cardiology URMC Strong Memorial Hospital Nov. 5, 2015 No disclosures 2 Aortic Stenosis- Management Challenges 1. True or a mistaken

More information

Cardiomegaly (The Enlarged Heart)

Cardiomegaly (The Enlarged Heart) Cardiomegaly (The Enlarged Heart) From Wikipedia, the free encyclopedia Cardiomegaly is a medical condition in which the heart is enlarged. It is more commonly referred to as an enlarged heart. The causes

More information

Carotid Stenting Current Indications. 24 August 2016 Christopher Bajzer

Carotid Stenting Current Indications. 24 August 2016 Christopher Bajzer Carotid Stenting Current Indications 24 August 2016 Christopher Bajzer Conflict of Interest None Carotid Atherosclerosis Why Intervene? Annual risk of having a stroke is a function of degree of stenosis

More information

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging Background: Reason: preoperative assessment of CAD, Shortness of Breath Symptom: atypical chest pain Risk factors: hypertension Under influence: a beta blocker Medications: digoxin Height: 66 in. Weight:

More information

Normal GFR values are ml/min/1.73 m2 in young men, and ml/min/1.73 m2 in young women.

Normal GFR values are ml/min/1.73 m2 in young men, and ml/min/1.73 m2 in young women. Management of ACS in Patients on Hemodialysis Dr. Ahmed El Zayat. MD, MRCP Cardiology Lecturer Zagazig University Normal GFR values are 100 130 ml/min/1.73 m2 in young men, and 90 120 ml/min/1.73 m2 in

More information

Stable Ischemic Heart Disease: When and How to Revascularize. Robert N. Jones, MD

Stable Ischemic Heart Disease: When and How to Revascularize. Robert N. Jones, MD Stable Ischemic Heart Disease: When and How to Revascularize Robert N. Jones, MD 1 I have no financial disclosures to make 2 3 4 Outline Basics of coronary bypass grafting Chronic stable coronary artery

More information

Perioperative Cardiac Care. Wendy Willmore BSc MD

Perioperative Cardiac Care. Wendy Willmore BSc MD Perioperative Cardiac Care Wendy Willmore BSc MD Overview Risk Assessment Preventive modalities Treatment of perioperative cardiac disease Assessment of Risk History and Physical Assess for history and

More information

Noninvasive Cardiology Focused Review. Asymptomatic Aortic and Mitral Regurgitation: How Should I Follow the Patient in Practice?

Noninvasive Cardiology Focused Review. Asymptomatic Aortic and Mitral Regurgitation: How Should I Follow the Patient in Practice? Asymptomatic Aortic and Mitral Regurgitation: How Should I Follow the Patient in Practice? Robert O. Bonow, MD, Division of Cardiology, Northwestern University Medical School, Chicago, Illinois During

More information

Stress Echocardiography and Valvular Heart Disease. Susan Wilansky, MD, FRCP(C), FACC, FASE Mayo Clinic, AZ

Stress Echocardiography and Valvular Heart Disease. Susan Wilansky, MD, FRCP(C), FACC, FASE Mayo Clinic, AZ Stress Echocardiography and Valvular Heart Disease Susan Wilansky, MD, FRCP(C), FACC, FASE Mayo Clinic, AZ DISCLOSURE Relevant Financial Relationship(s) None Off Label Usage None Objectives General indications

More information

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Appropriate Use: Big Brother is Watching Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Disclosures Consultant Boston Scientific, Medtronic, Middle Peak Medical, Millipede,

More information

Chapter # 8 Your Heart and Heart Disease

Chapter # 8 Your Heart and Heart Disease Chapter # 8 Your Heart and Heart Disease Know what happened to your heart You Will Learn: 1) How the heart works 2) About common heart problems and how to manage them Chapter 8 Your Heart & Heart Disease

More information

FOR BOD / HOD INFORMATION

FOR BOD / HOD INFORMATION SUBJECT: Statement on Transesophageal Echocardiography (Clean) Page 1 STATEMENT ON TRANSESOPHAGEAL ECHOCARDIOGRAPHY Committee of Origin: Economics (Approved by the ASA House of Delegates on October 17,

More information

Stress Echo: Role in Pre- Operative Assessment. Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton

Stress Echo: Role in Pre- Operative Assessment. Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton Stress Echo: Role in Pre- Operative Assessment Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton TlkO Talk Outline Types stress echo Dobutamine stress echo for ischaemia

More information

Purpose of Preoperative Evaluation. Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery* Epidemiology

Purpose of Preoperative Evaluation. Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery* Epidemiology Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery* Based on a Report of the American College of Cardiology/American Heart AssociationTask Force on Practice Guidelines Purpose

More information

PROGRAM MEASURES & METRICS

PROGRAM MEASURES & METRICS PROGRAM MEASURES & METRICS Measure ID Measure Set Measure Description PINN-14# PINN-33+ Communication and Care Coordination Advance Care Plan: Percentage of patients aged 65 years and older who have an

More information

FAME 3 Trial: FFR-Guided PCI vs. CABG

FAME 3 Trial: FFR-Guided PCI vs. CABG FAME 3 Trial: FFR-Guided PCI vs. CABG William F. Fearon, M.D. Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Background: SYNTAX Trial One Year MACCE

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

Inquire about history of hypertension, diabetes, hypercholesterolemia, coronary artery disease, alcohol and illicit drug use

Inquire about history of hypertension, diabetes, hypercholesterolemia, coronary artery disease, alcohol and illicit drug use PHYSICAL ASSESSMENT History Vital Signs Cardiac Extremities Lung PSYCHOLOGICAL ASSESSMENT Depression Screen TESTS Evaluation of ventricular function Inquire about history of hypertension, diabetes, hypercholesterolemia,

More information

Data Collection Form. American Society of Nuclear Cardiology (ASNC) Patient & Procedure Information. Indications

Data Collection Form. American Society of Nuclear Cardiology (ASNC) Patient & Procedure Information. Indications Data Collection Form American Society of Nuclear Cardiology (ASNC) Patient & Procedure Information Site ID 901* : Study GUID 1* : MRN 2* : DOB 3 : / / Patient Zip Code 4 : Sex 5 : Male

More information

Chapter 22: Diagnostic Procedures for Cardiovascular Disease

Chapter 22: Diagnostic Procedures for Cardiovascular Disease Chapter 22: Diagnostic Procedures for Cardiovascular Disease American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:

More information

Cardiac Pulmonary Edema and Cardiogenic Shock

Cardiac Pulmonary Edema and Cardiogenic Shock Cardiac Pulmonary Edema and Cardiogenic Shock 胡為雄 Frank-Starling Law Stroke Volume End-Diastolic Pressure In the normal heart, the diastolic volume (preload) is the principal force that governs the strength

More information

Medical Management of Carotid Stenosis

Medical Management of Carotid Stenosis Medical Management of Carotid Stenosis Thomas F. Rehring, MD, FACS Disclosures: None Regional Department Chief Department of Vascular Therapy Colorado Permanente Medical Group Clinical Associate Professor

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease Asymptomatic 62 y/o male Long-standing heart murmur 2/6 SEM at base of heart PMI and carotid upstroke normal S2 splits normally ECG, CXR normal Valvular Heart Disease What would

More information

Endorsement Summary: Cardiovascular Measures

Endorsement Summary: Cardiovascular Measures January 2012 Purpose of the Project The human and financial costs of cardiovascular disease are enormous. Heart disease is the leading cause of death for men and women in the United States and was estimated

More information

Symptoms of heart failure with normal ECG

Symptoms of heart failure with normal ECG Symptoms of heart failure with normal ECG F. Mut, A. Beltran, M. Kapitan Nuclear Medicine Service, Italian Hospital & CUDIM Montevideo, Uruguay Clinical history Woman 63 y.o. Overweight, hypertension,

More information

Stress Testing: Indications and Modalities. Wael A. Jaber, MD, FACC Section of Cardiovascular Imaging Heart and Vascular Institute Cleveland Clinic

Stress Testing: Indications and Modalities. Wael A. Jaber, MD, FACC Section of Cardiovascular Imaging Heart and Vascular Institute Cleveland Clinic Stress Testing: Indications and Modalities Wael A. Jaber, MD, FACC Section of Cardiovascular Imaging Heart and Vascular Institute Cleveland Clinic Why Stress Testing? Diagnosis, Prognosis, and Response

More information

SPRINT: A RANDOMIZED TRIAL OF INTENSIVE VERSUS STANDARD BLOOD-PRESSURE CONTROL

SPRINT: A RANDOMIZED TRIAL OF INTENSIVE VERSUS STANDARD BLOOD-PRESSURE CONTROL 1 SPRINT: A RANDOMIZED TRIAL OF INTENSIVE VERSUS STANDARD BLOOD-PRESSURE CONTROL Presenter: Mackenzie Clark, PharmD, BCPS University of California, San Francisco Medical Center 2 Disclosures I have no

More information

Dr Anil Aggarwala. Cardiac Health Institute. SAN Talk. Diagnosis of Coronary Artery Disease Symptoms Treadmill testing Stress echo Sestamibi studies

Dr Anil Aggarwala. Cardiac Health Institute. SAN Talk. Diagnosis of Coronary Artery Disease Symptoms Treadmill testing Stress echo Sestamibi studies Dr Anil Aggarwala Cardiac Health Institute SAN Talk 1 16 th September 2011 Diagnosis of Coronary Artery Disease Symptoms Treadmill testing Stress echo Sestamibi studies 2 CT angiography Cardiac catheterisation

More information

Patients with heart disease who need non cardiac surgery?

Patients with heart disease who need non cardiac surgery? How should I manage Patients with heart disease who need non cardiac surgery? Dr Bethan Freestone Birmingham Heartlands Cardiology update day 10 October 2016 Learning objectives How to go about evaluating

More information

PEDLATRIC CARDIOLOGY

PEDLATRIC CARDIOLOGY PEDLATRIC CARDIOLOGY Carl Gumbiner, M.D. Cardiology Section of AAP established - 1957 Sub board of ASP established - 1901 Currently 1074 Board Certified Pediatric Cardiologists 48 Pediatric Cardiology

More information

Current and Emerging Therapies in the Management of Ischemic Heart Disease. Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery

Current and Emerging Therapies in the Management of Ischemic Heart Disease. Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery Current and Emerging Therapies in the Management of Ischemic Heart Disease Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery Case 1 51 year old male patient History of Paroxysmal atrial

More information

Coronary Artery Disease Clinical Practice Guideline Summary

Coronary Artery Disease Clinical Practice Guideline Summary NATIONAL CLINICAL PRACTICE GUIDELINE Coronary Artery Disease Clinical Practice Guideline Summary This guideline is informational only. It is not intended or designed as a substitute for the reasonable

More information

Myocardial Perfusion SPECT Imaging in Patient with Left Bundle Branch Block Case report

Myocardial Perfusion SPECT Imaging in Patient with Left Bundle Branch Block Case report Myocardial Perfusion SPECT Imaging in Patient with Left Bundle Branch Block Case report Venjamin Majstorov, MD, PhD Institute of Pathophysiology and Nuclear Medicine Medical Faculty Skopje A 71-y-old man

More information

Cardiac Catheterization in Patients with Pulmonary Hypertension

Cardiac Catheterization in Patients with Pulmonary Hypertension Cardiac Catheterization in Patients with Pulmonary Hypertension Russel Hirsch, M.D. And James Tarver, M.D. Cincinnati Chldren s Hospital Medical Center And Orlando Heart Center Disclosures Russel Hirsch

More information

Clinical Manifestations

Clinical Manifestations Cardiac Sarcoidosis Vera H. Rigolin, MD Vice-President, American Society of Echocardiography Professor of Medicine Northwestern University Bluhm Cardiovascular Institute Medical Director, Echocardiography

More information

Exercise Stress Electrocardiography. Historical Perspective. Historical Perspective. Subject Population. Learning Objectives. ECG Exercise Testing

Exercise Stress Electrocardiography. Historical Perspective. Historical Perspective. Subject Population. Learning Objectives. ECG Exercise Testing Learning Objectives Exercise Stress Electrocardiography Gerald F. Fletcher MD Mayo Clinic Florida No Disclosures Provide an understanding of the value of the multiple ECG and Physiological measures that

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI?

Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI? Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI? Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ,

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Case studies: congenital heart disease

Case studies: congenital heart disease Case studies: congenital heart disease AAIM Audio Series Gordon R Cumming MD, FRCPC, FACC moderator: Marianne E Cumming MSc, MD March 5, 2014 Table of Contents / Agenda Coarctation of the aorta Ventricular

More information

Typical chest pain with ECG changes

Typical chest pain with ECG changes Typical chest pain with ECG changes F. Mut, C. Bentancourt, M. Beretta Nuclear Medicine Service, Asociacion Española Montevideo, Uruguay Clinical history Male 58 y.o. Diabetic, smoker, hypertension (poorly

More information

Preoperative Evaluation. Tyler Schwiesow MD UnityPoint Central Iowa Hospitalists

Preoperative Evaluation. Tyler Schwiesow MD UnityPoint Central Iowa Hospitalists Preoperative Evaluation Tyler Schwiesow MD UnityPoint Central Iowa Hospitalists (no conflict of interests to disclose) Case 100 y/o WF, presents to ER after fall. Found to have hip fracture. Admitted to

More information

Atrial Fibrillation Management Across the Spectrum of Illness

Atrial Fibrillation Management Across the Spectrum of Illness Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Background 8 th Coronary Physiology in the CathLab Course Revascularisation of intermediate stenosis can be targeted EITHER

More information

Cardiotoxicity in Aging Survivors of Childhood Cancer

Cardiotoxicity in Aging Survivors of Childhood Cancer Cardiotoxicity in Aging Survivors of Childhood Cancer Gregory T. Armstrong Assistant Member Department of Epidemiology and Cancer Control Proportion Surviving 100 Cancer Survival, 0 14 Years of Age SEER

More information

Cardiac Stress Testing in Nuclear Cardiology

Cardiac Stress Testing in Nuclear Cardiology Cardiac Stress Testing in Nuclear Cardiology Gaiane Doubinina, RN, MSN, FNP BC Nurse Practitioner, Nuclear Medicine/Cardiac Imaging Learning Objectives: Indications for stress testing Contraindication

More information

Chronic ischemic heart disease. 2/27/2016 Drew Fowler, MD, FACC

Chronic ischemic heart disease. 2/27/2016 Drew Fowler, MD, FACC Chronic ischemic heart disease 2/27/2016 Drew Fowler, MD, FACC Background Acute MI is the leading cause of death in North America and Europe. Each year, an estimated 785,000 Americans will sustain a

More information

Cardiac Rehab Why Are We Underutilizing This Powerful Intervention?

Cardiac Rehab Why Are We Underutilizing This Powerful Intervention? Cardiac Rehab Why Are We Underutilizing This Powerful Intervention? August 20, 2016 Chad Raymond, DO, FACC Director Cardiac Rehabilitation CCF Euclid and South Pointe Hospitals Goals/Objectives Really,

More information

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Srinivasan Rajagopal M.D. Assistant Professor Division of Cardiothoracic Anesthesia Objectives Describe the pathophysiology

More information

stress test for evaluation of exertional dyspnea

stress test for evaluation of exertional dyspnea Stress echo for assessment of dyspnea Michael H. Picard Massachusetts General Hospital Harvard Medical School No disclosures stress test for evaluation of exertional dyspnea CAD Non-ischemic cardiomyopathy

More information

BACKGROUND RECOMMENDATIONS

BACKGROUND RECOMMENDATIONS KAISER PERMANENTE OHIO ATRIAL FIBRILLATION Methodology: Evidence-Based Issue Date: 3-97 Champion: Cardiology Most Recent Updates: 9-03,12-05, 2-07, 1-09 Key Stakeholders: Cardiology, IM Next Update: 3-11

More information

Atrial Fibrillation The Basics

Atrial Fibrillation The Basics Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation

More information

RECENT ADVANCES TACOMA CARDIOLOGY CONFERENCE 14 OCTOBER in HEART FAILURE: Drugs, Devices, and Diastolic Dysfunction TOBIAS LEE, MD

RECENT ADVANCES TACOMA CARDIOLOGY CONFERENCE 14 OCTOBER in HEART FAILURE: Drugs, Devices, and Diastolic Dysfunction TOBIAS LEE, MD RECENT ADVANCES in HEART FAILURE: Drugs, Devices, and Diastolic Dysfunction TOBIAS LEE, M.D. TACOMA CARDIOLOGY CONFERENCE 14 OCTOBER 2006 GOALS OF DISCUSSION Quick Review of Heart Failure. Update on Drug

More information

IMR in Stable Patients. William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center

IMR in Stable Patients. William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center IMR in Stable Patients William F. Fearon, MD Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Indications for IMR in Stable Patients To evaluate the

More information

Myocardial Viability Imaging with SPECT, PET and CMR

Myocardial Viability Imaging with SPECT, PET and CMR Strength and Weaknesses of Myocardial Viability Imaging with SPECT, PET and CMR Thomas H Schindler, MD, PhD Cardiovascular Center, Division of Cardiology, Nuclear Cardiology Department of Internal Medecine,

More information

Implantable Defibrillators:

Implantable Defibrillators: Implantable Defibrillators: Who Should Get One? Malcolm Kirk, M.D., F.A.C.C. Our Target: Magnitude of Sudden Cardiac Arrest (SCA) in the U.S. Stroke 3 167,366 Lung Cancer 2 157,400 SCA claims nearly as

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Underwriting NT-proBNP. NEHOUA Fall 2014 Michael Clark, MD FACC DBIM

Underwriting NT-proBNP. NEHOUA Fall 2014 Michael Clark, MD FACC DBIM Michael Clark, MD FACC DBIM Agenda: BNP FAQs Case 1: Deciding on BNP thresholds Case 2,3: BNP and co-morbidities Case 4,5: BNP and "offsets" And some other brain teasers. 2 BNP Discovery and development

More information

Common Clinical Problems CHEST PAIN. Chest Pain Evaluation 9/25/2014. Southeast Regional Heart and Vascular Symposium for Primary Care Providers

Common Clinical Problems CHEST PAIN. Chest Pain Evaluation 9/25/2014. Southeast Regional Heart and Vascular Symposium for Primary Care Providers Southeast Regional Heart and Vascular Symposium for Primary Care Providers Imaging: Which Test is Best? William P. Warren, MD, FACC Common Clinical Problems Atrial Fibrillation Congestive Heart Failure

More information

Ischemic coronary disease without significant coronary lesions. What are the options?

Ischemic coronary disease without significant coronary lesions. What are the options? CARDIOLOGY HIGHLIGHTS 2013 Ischemic coronary disease without significant coronary lesions. What are the options? Maja Strozzi Department of Cardiovascular Diseases Zagreb University Hospital Center Croatia

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Chronic Aortic and Mitral Regurgitation

Chronic Aortic and Mitral Regurgitation 32 nd Annual Advances in Heart Disease Chronic Aortic and Mitral Regurgitation When Should We Intervene? Gabriel Gregoratos, MD, FACC Disclosure Statement Nothing to Disclose 1 Valvular Regurgitation:

More information